drugset / Trial / NCT06115174

Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer

NCT06115174

Phase 4 Unknown 44 enrolled Tanta University
RandomizedParallel-groupOpen-labelOther

Summary

The aim of this work is to assess the antitumor effect of Pentoxiphylline in patients with metastatic colorectal cancer receiving stomatal chemotherapy ± targeted therapy.

Timeline

Start
2023-11-01
Primary completion
2024-11-01
Completion
2024-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pentoxifylline Small molecule 400 mg
Background Bevacizumab Monoclonal antibody

Indications